Compile Data Set for Download or QSAR
Report error Found 219 Enz. Inhib. hit(s) with all data for entry = 50041965
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419705(CHEMBL1945295)
Affinity DataEC50:  40nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419662(CHEMBL1945294)
Affinity DataEC50:  0.631nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419706(CHEMBL1945296)
Affinity DataEC50:  1.30nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419664(CHEMBL1945298)
Affinity DataEC50:  2.5nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419663(CHEMBL1945297)
Affinity DataEC50:  0.794nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419666(CHEMBL1945300)
Affinity DataEC50:  32nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419665(CHEMBL1945299)
Affinity DataEC50:  0.398nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM86453(NSC_3083544 | CAS_73573-87-2 | Formoterol)
Affinity DataEC50:  1nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50128690(SB-07499 | 4-Hydroxy-7-{2-[2-(3-phenethyloxy-propa...)
Affinity DataEC50:  0.631nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419669(CHEMBL1944690)
Affinity DataEC50:  0.251nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419700(CHEMBL1944689)
Affinity DataEC50:  0.316nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419670(CHEMBL1944691)
Affinity DataEC50:  0.158nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419671(CHEMBL1944693)
Affinity DataEC50:  0.316nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419701(CHEMBL1944692)
Affinity DataEC50:  0.398nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419673(CHEMBL1944695)
Affinity DataEC50:  0.251nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419672(CHEMBL1944694)
Affinity DataEC50:  0.316nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetAlpha-1D adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419680(CHEMBL1945039)
Affinity DataEC50:  126nMAssay Description:Binding affinity to Alpha-1D adrenoceptor expressed in HEK cells by calcium flux assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419686(CHEMBL1945503)
Affinity DataEC50:  2.5nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50318159(CHEMBL1095777 | 8-Hydroxy-5-[(R)-1-hydroxy-2-(5,6-...)
Affinity DataEC50:  16nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419667(CHEMBL1945504)
Affinity DataEC50:  7.90nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419697(CHEMBL1947154)
Affinity DataEC50:  10nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419698(CHEMBL1947155)
Affinity DataEC50:  4nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419674(CHEMBL1945031)
Affinity DataEC50:  0.316nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419696(CHEMBL1947153)
Affinity DataEC50:  1nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419689(CHEMBL1945033)
Affinity DataEC50:  0.501nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419675(CHEMBL1945032)
Affinity DataEC50:  0.251nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419677(CHEMBL1945035)
Affinity DataEC50:  1.60nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419699(CHEMBL1947156)
Affinity DataEC50:  0.631nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419676(CHEMBL1945034)
Affinity DataEC50:  0.200nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetD(2) dopamine receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419680(CHEMBL1945039)
Affinity DataEC50:  251nMAssay Description:Binding affinity to dopamine D2 receptor expressed in HEK cells by GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM25771(salmeterol xinafoate | 4-(1-hydroxy-2-{[6-(4-pheny...)
Affinity DataEC50:  0.794nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419679(CHEMBL1945037)
Affinity DataEC50:  0.501nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419678(CHEMBL1945036)
Affinity DataEC50:  0.398nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419690(CHEMBL1946761)
Affinity DataEC50:  100nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419691(CHEMBL1946762)
Affinity DataEC50:  79nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419694(CHEMBL1946765)
Affinity DataEC50:  4nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419668(CHEMBL1947157)
Affinity DataEC50:  0.501nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419695(CHEMBL1946766)
Affinity DataEC50:  316nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419692(CHEMBL1946763)
Affinity DataEC50:  158nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419693(CHEMBL1946764)
Affinity DataEC50:  158nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419702(CHEMBL1945038)
Affinity DataEC50:  1nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419681(CHEMBL1945040)
Affinity DataEC50:  3.20nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419680(CHEMBL1945039)
Affinity DataEC50:  0.631nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419703(CHEMBL1945042)
Affinity DataEC50:  0.631nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419682(CHEMBL1945041)
Affinity DataEC50:  0.316nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419684(CHEMBL1945044)
Affinity DataEC50:  1nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419683(CHEMBL1945043)
Affinity DataEC50:  0.631nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419704(CHEMBL1945289)
Affinity DataEC50:  0.794nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419659(CHEMBL1945291)
Affinity DataEC50:  3.20nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419685(CHEMBL1945290)
Affinity DataEC50:  3.20nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
Displayed 1 to 50 (of 219 total ) | Next | Last >>
Jump to: